These comprehensive 30-page study notes are designed to build a deep conceptual understanding of pediatric rheumatology,
focusing on the pathophysiology, clinical reasoning, and management of these complex conditions.
Page 1: Defining Pediatric Arthritis
The Diagnostic Criteria
Arthritis in children is not a single diagnosis but a clinical finding. It is officially present if there is swelling or effusion in a joint. If
swelling is absent, arthritis is diagnosed if at least two of the following four features are present:
1. Limitation of range of motion: The joint cannot move through its full normal path.
2. Pain: Physical discomfort in the joint.
3. Tenderness: Pain provoked specifically by touching or moving the joint.
4. Increased heat: The skin over the joint feels warmer than the surrounding tissue.
Clinical Reasoning: History vs. Labs
A common mistake is over-relying on blood tests. Clinical assessment (history and physical examination) is far superior and
provides more diagnostic clues than indiscriminate laboratory testing.
Page 2: Classification by Duration
A logical way to narrow down the cause of arthritis is by how long the child has been ill.
Duration Classification Common Causes
< 2 Weeks Acute Acute rheumatic fever, Septic
arthritis, Transient ('toxic') synovitis .
2 – 6 Weeks Subacute Reactive arthritis, SLE, Leukemia,
Sickle cell disease .
> 6 Weeks Chronic
Juvenile Idiopathic Arthritis (JIA),
Tubercular arthritis, Psoriasis .
Reasoning for Timing
● Acute: Usually infectious or a rapid post-infectious immune response.
● Chronic: Suggests an underlying autoimmune or persistent inflammatory process.
Page 3: Transient Synovitis – The "Common Cold" of the Hip
Concept Building
Transient synovitis is the most common cause of hip pain in young children.
● Trigger: It usually follows an upper respiratory infection (catarrh).
● Clinical Reasoning: It is self-limiting, lasting only 2–4 days. It must be differentiated from septic arthritis to avoid
unnecessary surgery.
● Management: Simple rest (skin traction) and NSAIDs bring prompt relief.
Page 4: Septic Arthritis – The Surgical Emergency
Clinical Features
Usually presents in neonates and infants as monoarthritis (one joint), accompanied by high fever and severe limitation of
movement.
Pathogenic Reasoning (By Age)
● Neonates: Gram-negative bacilli, Group B streptococci.
● Infants: Haemophilus influenzae type B, S. pneumoniae.
● Older Children: Staphylococcus aureus.
Management Reasoning
Diagnostic arthrocentesis (joint fluid aspiration) is mandatory to confirm the diagnosis and identify the bacteria. The hip joint
often requires open drainage because pressure buildup can cut off the blood supply to the femoral head.
Page 5: Synovial Fluid Analysis – The Laboratory Key
Comparing fluid characteristics helps distinguish infection from inflammation :
● Septic: Turbid fluid, reduced glucose (bacteria eat the sugar), high protein, and mostly polymorphonuclear cells.
● SLE: Clear fluid, normal glucose, and lymphocytes present.
● JIA: Cloudy fluid with low glucose; it often mimics septic arthritis fluid, but the Gram stain is negative.
Page 6: Introduction to Juvenile Idiopathic Arthritis (JIA)
The Formal Definition
JIA is the most common rheumatological disorder in children. It is defined as:
● Arthritis in one or more joints.
● Onset below 16 years of age.
● Persisting for at least 6 weeks.
Pathogenesis Concepts
It is not a single disease but a group of conditions.
● Innate vs. Acquired: Systemic JIA (sJIA) is an auto-inflammatory disorder of the innate immune system. Other types
represent defects in acquired immunity.
● Cytokines: TNF-$\alpha$, IL-6, and IL-1 play major roles in the inflammatory "storm".
Page 7: Systemic JIA (sJIA) – The Fever-First Pattern
Defining Features
sJIA accounts for 5–15% of cases. It requires fever for at least 2 weeks plus one of the following:
● Evanescent rash: A pink, truncal rash that comes and goes with the fever.
● Generalized lymphadenopathy.
● Hepatosplenomegaly (enlarged liver/spleen).
● Serositis (inflammation of heart or lung linings).
Clinical Reasoning
Fever usually peaks twice daily, typically in the evening. Children are very irritable while febrile but feel better when the fever
drops.
Page 8: Oligoarthritis – The Most Common Type
Concept Building
This is the most frequent type (60–70% of patients).
● Count: 4 or fewer joints involved in the first 6 months.
● Subtypes: Persistent (stays $\le 4$ joints) or Extended (exceeds 4 joints after the first 6 months).
● Typical Patient: A girl aged 3–5 with an asymmetric swollen knee or ankle.
The Blinding Complication
25% of these children develop iridocyclitis (chronic eye inflammation).
● Reasoning: It is asymptomatic (silent) but can cause permanent blindness. ANA-positive girls are at the highest risk and
need regular screening by an ophthalmologist.
Page 9: Polyarthritis – The Deforming Pattern
Overview
Involves more than 4 joints. It is more common in girls and causes pain out of proportion to the swelling .
RF Negative Subtype
● Can occur at any age.
● Less severe than the RF positive form .
RF Positive Subtype
● Occurs in late childhood/adolescence.
● Clinical Reasoning: It is the only pediatric category similar to adult rheumatoid arthritis. It is symmetrical, additive, and
severe, typically destroying the small joints of the hands.
Page 10: Enthesitis-Related Arthritis (ERA)
Key Features
● More common in older boys ($>8$ years).
● Affects large joints of the lower extremities asymmetrically.
● HLA B27 Link: Many patients are HLA B27 positive and may develop ankylosing spondylitis as adults.
Enthesitis Reasoning
"Enthesitis" is inflammation where tendons or ligaments attach to bone. Children often have a family history of back pain,
psoriasis, or Reiter disease.
Page 11: JIA Management – The Multidisciplinary Strategy
The Goal
Prevent permanent disability and flexion contractures, and facilitate "mainstreaming" in school.
Physiotherapy Reasoning
Physical therapy is as important as drugs; it maintains joint mobility and muscle strength while preventing fixed deformities.
Medical Mainstays
● NSAIDs: Naproxen and Ibuprofen are the first lines for symptom relief .
● Intra-articular steroids: The preferred choice for children with oligoarthritis who don't respond to NSAIDs.
Page 12: JIA Management – DMARDs and Biologics
Methotrexate (The Gold Standard)
Started in almost all polyarthritis cases.
● Reasoning: Given weekly, it simplifies management and is better tolerated by children than adults .
Biologics – The Modern Targeted Strike
Used when conventional drugs fail.
● Anti-TNF: Etanercept, Infliximab, Adalimumab .
● Anti-IL-1: Anakinra, Canakinumab (favored in sJIA).
● Anti-IL-6: Tocilizumab (useful in severe sJIA).
Page 13: Systemic Lupus Erythematosus (SLE) – Fundamentals
Defining Concept
An autoimmune disorder characterized by multisystem inflammation of connective tissues and blood vessels.
The Hallmark
The presence of Antinuclear Antibodies (ANA) is the diagnostic hallmark found in almost all patients.
Pediatric Reasoning
Childhood SLE is usually more severe and has a poorer prognosis than the adult form. Interestingly, the marked female
predominance seen in adults is less apparent in young children.
Page 14: SLE – Clinical Features
Skin Manifestations
● Malar Rash: Virtually pathognomonic. It involves the cheeks and nose bridge but spares the nasolabial folds .
● Frontal Alopecia: Hair loss specifically at the front of the scalp.
Other Features
● Arthritis: Generally mild and, unlike JIA, it is non-erosive (doesn't destroy the bone).
● Oral Ulcers: Usually painless; found on the palate or buccal mucosa.
Page 15: Lupus Nephritis – The Major Threat
Pathology Concept
Renal involvement is a dreaded complication and a leading cause of death.
Classification (I – VI)
● Class I & II: Minimal/Mesangial changes.
● Class III & IV: Proliferative changes. These are the most dangerous and require aggressive therapy .
● Class V & VI: Membranous and Advanced sclerosing.
Clinical Reasoning
If a child has biopsy-proven lupus nephritis and a positive ANA, they fulfill the SLICC classification criteria for SLE regardless of
other features.
Page 16: SLE – Diagnostic Criteria (SLICC)
To reach a clinical diagnosis, a patient generally needs at least 4 criteria (with at least 1 clinical and 1 laboratory).
Clinical Criteria Immunologic Criteria
Acute/Chronic Cutaneous Lupus ANA
Oral/Nasal ulcers Anti-dsDNA
Non-scarring alopecia Anti-Smith
Arthritis or Serositis Antiphospholipid Ab
Renal or Neurologic involvement Low Complement (C3/C4)
Hemolytic anemia or Leukopenia Direct Coombs' test
Page 17: SLE – Serology and Auto-antibodies
Anti-dsDNA
Highly specific for SLE. Levels often rise and fall with disease activity, making it a good marker for monitoring.
Anti-Sm (Smith)
Specific for SLE and acts as a marker for CNS involvement.
Neonatal Lupus Markers
● Anti-Ro: Associated with congenital heart block.
● Anti-histone: Characteristic of drug-induced lupus.
Page 18: SLE – Management Concepts
The Mainstays
● Glucocorticoids (Prednisolone): The primary treatment for inflammation.
● Hydroxychloroquine: Essential for all patients to prevent flares and manage skin/joint issues.
Emergency/Pulse Therapy
Life-threatening situations (encephalopathy, myocarditis, severe nephritis) require IV pulse methylprednisolone for 3–5 days.
Sun Protection Reasoning
UV light triggers lupus flares. Sunscreens (SPF 15–20) must be applied 3–4 times daily, even on cloudy days.
Page 19: SLE – Advanced Immunosuppression
Cyclophosphamide
Used in monthly IV pulses to treat severe lupus nephritis, significantly improving long-term survival.
Maintenance Therapy
Once the kidneys are stable, the patient is switched to:
● Mycophenolate mofetil: Increasingly favored in children.
● Azathioprine: A conventional alternative.
Rituximab
A monoclonal antibody (anti-CD20) used in refractory, life-threatening situations.
Page 20: Antiphospholipid Syndrome (APS)
The Concept
A common accompaniment to SLE that causes an acquired hypercoagulable state (the blood clots too easily) .
Clinical Markers
● Venous/Arterial thrombosis.
● Livedo Reticularis: A mottled, lace-like purple pattern on the skin.
● Thrombocytopenia (low platelets).
Laboratory Reasoning
Diagnosis shows a prolonged partial thromboplastin time (PTT) that doesn't correct with normal plasma, and positive
anticardiolipin antibodies or the lupus anticoagulant.
Page 21: Juvenile Dermatomyositis (JDM) – Pathophysiology
Defining Concept
A multisystem disease characterized by non-suppurative inflammation of striated muscle and skin, along with systemic
vasculopathy.
The Diagnostic Criteria
A definite diagnosis requires the first skin criterion plus any three of the remaining four:
1. Characteristic Rash: Heliotrope rash or Gottron papules.
2. Symmetrical proximal muscle weakness: Difficulty climbing stairs or getting up from the floor.
3. Elevated muscle enzymes: Creatine kinase, aldolase, AST/ALT.
4. EMG evidence of myopathy.
5. Muscle biopsy evidence (rarely needed today).
Page 22: JDM – Clinical Rashes
Heliotrope Rash
A characteristic violet/purple discoloration over the upper eyelids, often accompanied by swelling (edema).
Gottron Papules
Scaly, red bumps found over the dorsal aspects (knuckles) of the MCP and PIP joints.
Pathology Concept
Unlike adults, children almost never have "pure polymyositis" (muscle weakness without a rash).
Page 23: JDM – Management & MRI
MRI Reasoning
MRI is now the preferred way to "see" inflammation. It shows muscle edema (hyperintense signals) on T2-weighted images.
Treatment Strategy
● Steroid Pulses: Initial high-dose IV methylprednisolone.
● Maintenance: Weekly oral or subcutaneous Methotrexate is the mainstay for 18–24 months.
● Tapering Caution: Tapering steroids too quickly often leads to a disease relapse.
Page 24: Vasculitides – Classification Concepts
Vasculitis is classified primarily by the size of the blood vessel affected.
Vessel Size Disease Examples Primary Concern
Large Takayasu Arteritis Stenosis/weak pulses.
Medium Aneurysms (especially coronary).
Kawasaki Disease, PAN
Small Purpura, renal/GI issues.
IgA Vasculitis (HSP), Wegener
Pathology Reasoning
The location and size of the affected vessel determine whether the child presents with a skin rash, a "pulseless" limb, or a heart
attack.
Page 25: Kawasaki Disease (KD) – The Heart at Risk
Key Concept
KD is an acute febrile vasculitis mainly affecting children under 5 . It is now the leading cause of acquired heart disease in many
countries, having replaced rheumatic fever.
The Danger
Necrotizing vasculitis can cause coronary artery aneurysms in 15–25% of untreated patients.
Diagnostic Reasoning
There is no specific lab test. Diagnosis is based entirely on recognizing a temporal sequence of clinical findings.
Page 26: Kawasaki Disease – Diagnostic Criteria
A child must have fever for at least 5 days plus 4 of the following 5 :
1. Conjunctival injection: Bilateral, red eyes without discharge.
2. Oral mucosal changes: Red, cracked lips; strawberry tongue; or red pharynx.
3. Extremity changes: Swollen/red hands/feet initially; periungual peeling (peeling around nails) later.
4. Polymorphous rash: Not blistering (vesicular).
5. Cervical lymphadenopathy: Usually one large unilateral node ($>1.5$ cm).
Page 27: Kawasaki Disease – Clinical Clues
Irritability
Affected children are often extremely irritable. This clinical clue often provides the first hint toward a KD diagnosis .
BCG Scar Reactivation
In infants, the old BCG vaccine site may become red and inflamed—a highly characteristic sign.
Beau Lines
Transverse grooves in the nails seen during the recovery phase.
Page 28: Kawasaki Disease – Management
The Rescue Dose
● IVIG (Intravenous Immunoglobulin): A single high dose ($2$ g/kg).
● Reasoning: If given early, it reduces the risk of coronary aneurysms to less than 3%.
Aspirin Protocol
● High dose: Given while the child has a fever for its anti-inflammatory effect.
● Low dose: Continued for 4–6 weeks for its antiplatelet activity to prevent clots in inflamed vessels.
Page 29: IgA Vasculitis (Henoch-Schönlein Purpura)
Defining Concept
The most common vasculitis of childhood. It involves non-thrombocytopenic purpura, joint pain, and abdominal issues.
The Diagnostic Triad
1. Palpable Purpura: Bumps/spots on the skin, typically on the lower limbs and buttocks.
2. Abdominal Pain: Colicky, intermittent pain caused by vasculitis of the bowel wall .
3. Arthritis/Arthralgia: Transient joint issues.
Renal Reasoning
IgA deposits in the kidney can lead to glomerulonephritis. While most cases resolve in 4 weeks, children over 6 years old are at
higher risk for long-term renal failure .
Page 30: Takayasu Arteritis & PAN
Takayasu Arteritis
Known as "pulseless disease," it affects the aorta and its major branches.
● Reasoning: It is the leading cause of renovascular hypertension in India. Diagnosis is confirmed by angiography showing
stenosis or aneurysms.
Polyarteritis Nodosa (PAN)
A rare medium-vessel vasculitis.
● Clinical Clue: Livedo Reticularis (mottled skin) and hypertension (found in 80% of patients).
● Reasoning: Treatment requires long-term immunosuppression, often starting with Cyclophosphamide.
Next Step: Would you like a comparative diagnostic table for the different types of pediatric vasculitis to help with your final
exam review?